The effect of tamoxifen as an adjuvant therapy for breast cancer on apolipoproteins and lipoprotein(a) concentrations in women: A meta-analysis of randomized controlled trials
Experimental Gerontology · 2024-11 · 197 · 112587
DOI: 10.1016/j.exger.2024.112587 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Experimental Gerontology, 2024-11. Verfasst von Bohua Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, General Hospital of Central Theater Command, Wuhan 430010, China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Hormonal, Breast Neoplasms, Lipoprotein(a), Randomized Controlled Trials as Topic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND AND AIM: Tamoxifen has been used in the management of breast cancer. The available evidence on the effect of tamoxifen on lipoprotein(a) and apolipoproteins is controversial. Hence, this meta-analysis of randomized controlled trials (RCTs) was conducted to increase the quality of evidence on the effect of tamoxifen on lipoprotein(a) and apolipoproteins. METHODS: Eligible RCTs published up to September 2023 were carefully selected following a comprehensive search. Thereafter, a meta-analysis was conducted using a random-effects model and the results were presented as the weighted mean difference (WMD) with a 95 % confidence interval (CI). RESULTS: The results from the random-effects model indicated a rise in ApoA-I (WMD: 16.24 mg/dL, 95 % CI: 5.35, 27.12, P = 0.003), and a decrease in ApoB (WMD: -9.37 mg/dL, 95 % CI: -15.16, -3.59, P = 0.001) and lipoprotein(a) (WMD: -3.24 mg/dL, 95 % CI: -5.66, -0.83, P < 0.001) concentrations following tamoxifen administration in women. Furthermore, a more pronounced decrease in ApoB (WMD: -12.86 mg/dL, 95 % CI: -19.78, -5.93, P < 0.001) and elevation in ApoA-1 levels (WMD: 51.97 mg/dL, 95 % CI: 45.89, 58.05, P < 0.001) were identified in a single study on patients with breast cancer. CONCLUSION: The current meta-analysis demonstrated an increase of ApoA-I and a decrease of ApoB and lipoprotein(a) levels after treatment with tamoxifen in women.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, General Hospital of Central Theater Command, Wuhan 430010, China.
- Department of Clinical Pharmacy, General Hospital of Central Theater Command, Wuhan 430010, China.
- Cardiovascular Medicine, General Hospital of Central Theater Command, Wuhan 430010, China.
- Department of Pharmacy Practice, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia.
- University Center for Health Science, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico.
- Department of Pharmacy, General Hospital of Central Theater Command, Wuhan 430010, China. Electronic address: ydiyaya@163.com.
Zitieren
APA
Zhang, B., Huang, Y., Zhang, J., Fu, W., Prabahar, K., Hernández-Wolters, B., Hu, H., & Hao, F. (2024). The effect of tamoxifen as an adjuvant therapy for breast cancer on apolipoproteins and lipoprotein(a) concentrations in women: A meta-analysis of randomized controlled trials. Experimental Gerontology, 197, 112587. https://doi.org/10.1016/j.exger.2024.112587
Vancouver
Zhang B, Huang Y, Zhang J, Fu W, Prabahar K, Hernández-Wolters B, et al. The effect of tamoxifen as an adjuvant therapy for breast cancer on apolipoproteins and lipoprotein(a) concentrations in women: A meta-analysis of randomized controlled trials. Experimental Gerontology. 2024;197:112587. doi:10.1016/j.exger.2024.112587
BibTeX
@article{Zhang2024,
author = {Zhang, Bohua and Huang, Yafang and Zhang, Jingjing and Fu, Wenbo and Prabahar, Kousalya and Hernández-Wolters, Benjamin and Hu, Hua and Hao, Fei},
title = {The effect of tamoxifen as an adjuvant therapy for breast cancer on apolipoproteins and lipoprotein(a) concentrations in women: A meta-analysis of randomized controlled trials},
journal = {Experimental Gerontology},
year = {2024},
volume = {197},
pages = {112587},
doi = {10.1016/j.exger.2024.112587}
}
EUVIMED